ロード中...
Investigating the impact of open label design on patient‐reported outcome results in prostate cancer randomized controlled trials
BACKGROUND: While open‐label randomized controlled trials (RCT) are common in oncology, some concerns have been expressed with regard to Patient‐Reported Outcomes (PRO)‐based claims stemming from these studies. We aimed to investigate the impact of open‐label design in the context of prostate cancer...
保存先:
| 出版年: | Cancer Med |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley and Sons Inc.
2020
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7571808/ https://ncbi.nlm.nih.gov/pubmed/32846465 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.3335 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|